Viewing Study NCT05821361


Ignite Creation Date: 2025-12-24 @ 12:54 PM
Ignite Modification Date: 2026-01-06 @ 9:00 AM
Study NCT ID: NCT05821361
Status: UNKNOWN
Last Update Posted: 2023-04-20
First Post: 2023-04-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: HAIC Combined With Cadonilimab and Bevacizumab as First-line Therapy in Unresectable Hepatocellular Carcinoma
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module